Ionis Pharmaceuticals IONS Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's inventories?
- Ionis Pharmaceuticals (IONS) reported inventories of $5.56M in Q1 2026.
- How has Ionis Pharmaceuticals's inventories changed year-over-year?
- Ionis Pharmaceuticals's inventories decreased by 51.7% year-over-year, from $11.5M to $5.56M.
- What is the long-term trend for Ionis Pharmaceuticals's inventories?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's inventories has grown at a -14.5% compound annual growth rate (CAGR), from $21.97M to $10.05M.
- What does inventories mean?
- The total value of all raw materials and finished products currently held by the company.
- How do you interpret inventories?
- Rising inventory levels may signal anticipated demand or supply chain buildup, whereas declining levels might suggest efficient inventory management or potential supply shortages.
- How does inventories compare across companies?
- Varies significantly based on whether the company is in a clinical phase or has commercialized products.